ASHLEY BECK: Open Payments
NPI 1689398653 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 18 payments from 9 companies in 2025. Trend: 2023 $197 · 2024 $243 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $126 |
| E.R. Squibb & Sons, L.L.C. | 1 | $112 |
| ABBVIE INC. | 4 | $71 |
| Amgen Inc. | 3 | $50 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| PFIZER INC. | 1 | $20 |
| Medtronic, Inc. | 1 | $18 |
Products named: OPDIVO, AIRSUPRA, UBRELVY, FARXIGA, OTEZLA, QULIPTA, LEQVIO, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
